Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:49 UTC |
---|
HMDB ID | HMDB0014984 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Flurandrenolide |
---|
Description | Flurandrenolide is only found in individuals that have used or taken this drug. It is a corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. (From Martindale, The Extra Pharmacopoeia, 30th ed, p733)Flurandrenolide is a topical corticosteroid. It is normally applied to a plastic tape called Cordran. Cordran is primarily effective because of its anti-inflammatory, antipruritic, and vasoconstrictive actions. Flurandrenolide, which is slowly released from the Cordran tape, binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. Cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Like other glucocorticoid agents Fluocinolone acetonide acts as a physiological antagonist to insulin by decreasing glycogenesis (formation of glycogen). It also promotes the breakdown of lipids (lipolysis), and proteins, leading to the mobilization of extrahepatic amino acids and ketone bodies. This leads to increased circulating glucose concentrations (in the blood). There is also decreased glycogen formation in the liver. | Read more...
---|
Structure | [H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)CC[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO InChI=1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Fludroxycortide | Kegg | Cordran | Kegg | Floudroxycortide | HMDB | Fludrossicortide | HMDB | Fludroxicortidum | HMDB | Fluorandrenolone | HMDB | Fluorandrenolone acetonide | HMDB | Flurandrenolone | HMDB | Flurandrenolone acetonide | HMDB | Haelan | HMDB | Oclassen brand OF flurandrenolone | HMDB | Typharm brand OF flurandrenolone | HMDB |
|
---|
Chemical Formula | C24H33FO6 |
---|
Average Molecular Weight | 436.5136 |
---|
Monoisotopic Molecular Weight | 436.226116993 |
---|
IUPAC Name | (1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-17-en-16-one |
---|
Traditional Name | flurandrenolide |
---|
CAS Registry Number | 1524-88-5 |
---|
SMILES | [H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)CC[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO |
---|
InChI Identifier | InChI=1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1 |
---|
InChI Key | POPFMWWJOGLOIF-XWCQMRHXSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Hydroxysteroids |
---|
Direct Parent | 21-hydroxysteroids |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 21-hydroxysteroid
- Pregnane-skeleton
- 20-oxosteroid
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 6-halo-steroid
- Halo-steroid
- 11-hydroxysteroid
- 11-beta-hydroxysteroid
- Oxosteroid
- Delta-4-steroid
- Ketal
- Cyclohexenone
- Meta-dioxolane
- Alpha-hydroxy ketone
- Cyclic alcohol
- Ketone
- Secondary alcohol
- Cyclic ketone
- Acetal
- Organoheterocyclic compound
- Oxacycle
- Primary alcohol
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Alkyl halide
- Alkyl fluoride
- Alcohol
- Organohalogen compound
- Organofluoride
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 251 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.058 g/L | Not Available | LogP | 0.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Flurandrenolide,1TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O1 | 3103.1 | Semi standard non polar | 33892256 | Flurandrenolide,1TMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O1 | 3183.7 | Semi standard non polar | 33892256 | Flurandrenolide,1TMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 | 3154.5 | Semi standard non polar | 33892256 | Flurandrenolide,1TMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O1 | 3202.2 | Semi standard non polar | 33892256 | Flurandrenolide,2TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O1 | 3076.8 | Semi standard non polar | 33892256 | Flurandrenolide,2TMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O1 | 3052.8 | Semi standard non polar | 33892256 | Flurandrenolide,2TMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O1 | 3107.8 | Semi standard non polar | 33892256 | Flurandrenolide,2TMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O1 | 3136.2 | Semi standard non polar | 33892256 | Flurandrenolide,2TMS,isomer #5 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3183.6 | Semi standard non polar | 33892256 | Flurandrenolide,2TMS,isomer #6 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O1 | 3137.9 | Semi standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O1 | 3050.3 | Semi standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O1 | 3232.2 | Standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C)O1 | 3435.7 | Standard polar | 33892256 | Flurandrenolide,3TMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3085.4 | Semi standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3232.3 | Standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3471.9 | Standard polar | 33892256 | Flurandrenolide,3TMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O1 | 3066.0 | Semi standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O1 | 3183.3 | Standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C)O1 | 3530.7 | Standard polar | 33892256 | Flurandrenolide,3TMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3105.1 | Semi standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3314.9 | Standard non polar | 33892256 | Flurandrenolide,3TMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3555.0 | Standard polar | 33892256 | Flurandrenolide,4TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3055.7 | Semi standard non polar | 33892256 | Flurandrenolide,4TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3233.4 | Standard non polar | 33892256 | Flurandrenolide,4TMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C)O[Si](C)(C)C)O1 | 3434.1 | Standard polar | 33892256 | Flurandrenolide,1TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O1 | 3333.7 | Semi standard non polar | 33892256 | Flurandrenolide,1TBDMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O1 | 3448.2 | Semi standard non polar | 33892256 | Flurandrenolide,1TBDMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 | 3397.8 | Semi standard non polar | 33892256 | Flurandrenolide,1TBDMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O1 | 3426.3 | Semi standard non polar | 33892256 | Flurandrenolide,2TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O1 | 3555.5 | Semi standard non polar | 33892256 | Flurandrenolide,2TBDMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO)O1 | 3493.6 | Semi standard non polar | 33892256 | Flurandrenolide,2TBDMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O1 | 3548.7 | Semi standard non polar | 33892256 | Flurandrenolide,2TBDMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O1 | 3605.2 | Semi standard non polar | 33892256 | Flurandrenolide,2TBDMS,isomer #5 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3637.1 | Semi standard non polar | 33892256 | Flurandrenolide,2TBDMS,isomer #6 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O1 | 3587.1 | Semi standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O1 | 3689.3 | Semi standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O1 | 3847.0 | Standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=O)CO[Si](C)(C)C(C)(C)C)O1 | 3640.6 | Standard polar | 33892256 | Flurandrenolide,3TBDMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3732.2 | Semi standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3853.5 | Standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #2 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3663.3 | Standard polar | 33892256 | Flurandrenolide,3TBDMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O1 | 3694.1 | Semi standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O1 | 3761.1 | Standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #3 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO)O[Si](C)(C)C(C)(C)C)O1 | 3704.4 | Standard polar | 33892256 | Flurandrenolide,3TBDMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3765.1 | Semi standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3877.1 | Standard non polar | 33892256 | Flurandrenolide,3TBDMS,isomer #4 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3737.4 | Standard polar | 33892256 | Flurandrenolide,4TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3852.2 | Semi standard non polar | 33892256 | Flurandrenolide,4TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3948.8 | Standard non polar | 33892256 | Flurandrenolide,4TBDMS,isomer #1 | CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]5(C)[C@H]4[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]3(C)[C@]2(C(=CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O1 | 3674.9 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Flurandrenolide GC-MS (2 TMS) - 70eV, Positive | splash10-014i-0242190000-938550a71054495f50e4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flurandrenolide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flurandrenolide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide LC-ESI-qTof , Positive-QTOF | splash10-001s-3961000000-a326b0165af296ecf245 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide , positive-QTOF | splash10-001s-3961000000-a326b0165af296ecf245 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide 45V, Positive-QTOF | splash10-0ab9-2930000000-cd90ebd8b6bcbdff0113 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide 30V, Positive-QTOF | splash10-0101-1892000000-4a7a3215b7b92c4b5849 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide 30V, Positive-QTOF | splash10-0101-1892000000-5e67e16afeb176cac16f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide 45V, Positive-QTOF | splash10-0ab9-2930000000-135be0b7a10b1438ca01 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide 75V, Positive-QTOF | splash10-054o-4900000000-698c8e0c7a2c1b17adea | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flurandrenolide 75V, Positive-QTOF | splash10-054o-4900000000-a2803e4d1a9647bfb01c | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 10V, Positive-QTOF | splash10-014r-0001900000-8ab0b07154fa08fbd90e | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 20V, Positive-QTOF | splash10-0aor-2065900000-9325b21e5bdc8417f5f1 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 40V, Positive-QTOF | splash10-0bta-1392000000-e312185a8364edd39345 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 10V, Negative-QTOF | splash10-052r-1006900000-7aad85976b8cbc3f2dd7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 20V, Negative-QTOF | splash10-0ar9-2006900000-d7efad75f8beac5b5b6a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 40V, Negative-QTOF | splash10-0a4i-7119000000-7a16a8ee051b25956988 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 10V, Positive-QTOF | splash10-000i-0002900000-a75f37566ef563be73f5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 20V, Positive-QTOF | splash10-0170-0247900000-bf85161108e4ee5e5772 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 40V, Positive-QTOF | splash10-0ar3-2490000000-e63b46eb297d675f2717 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 10V, Negative-QTOF | splash10-000i-0000900000-237c434d76e103d4dd61 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 20V, Negative-QTOF | splash10-004r-0009500000-7662c4c1dc487a05e57a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Flurandrenolide 40V, Negative-QTOF | splash10-0bt9-9060600000-a4f103f5a13a922b4349 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00846 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00846 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00846 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 14475 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Fludroxycortide |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 15209 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 774963 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|